Skip Navigation



Human Molecular Genetics Advance Access published online on March 10, 2006

Human Molecular Genetics, doi:10.1093/hmg/ddl045
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Material
Right arrow All Versions of this Article:
15/8/1279    most recent
ddl045v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Taniguchi, M.
Right arrow Articles by Toda, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taniguchi, M.
Right arrow Articles by Toda, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved
Received October 15, 2005
Revised February 28, 2006
Accepted March 28, 2006

Article

Aberrant neuromuscular junctions and delayed terminal muscle fiber maturation in {alpha}-dystroglycanopathies

Mariko Taniguchi 1, Hiroki Kurahashi 2, Satoru Noguchi 3, Takayasu Fukudome 4, Takeshi Okinaga 5, Toshifumi Tsukahara 6, Youichi Tajima 7, Keiichi Ozono 5, Ichizo Nishino 3, Ikuya Nonaka 3, and Tatsushi Toda 1 *

1 Division of Clinical Genetics, Department of Medical Genetics, Osaka University Graduate School of Medicine, 2-2-B9 Yamadaoka, Suita, Osaka 565-0871, Japan
2 Division of Molecular Genetics, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan
3 National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8502, Japan
4 Department of Neurology, Kawatana National Hospital, Kawatanamachi, Nagasaki 859-3615, Japan
5 Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871 Japan
6 Nano Materials and Technology Center, Advanced Institute of Science and Technology, Tatsunokuchi, Ishikawa 923-1292, Japan
7 Department of Clinical Genetics, The Tokyo Metropolitan Institute of Medical Science, Bunkyo-ku, Tokyo 113-8613, Japan

* To whom correspondence should be addressed.
Tatsushi Toda, E-mail: toda{at}clgene.med.osaka-u.ac.jp


   Abstract

Recent studies have revealed an association between post-translational modification of {alpha}-dystroglycan ({alpha}-DG) and certain congenital muscular dystrophies known as seconday {alpha}-dystroglycanopathies ({alpha}-DGpathies). Fukuyama-type congenital muscular dystrophy (FCMD) is classified as a secondary {alpha}-DGpathy since the responsible gene, fukutin, is a putative glycosyltransferase for {alpha}-DG. To investigate the pathophysiology of secondary {alpha}-DGpathies, we profiled gene expression in skeletal muscle from FCMD patients. cDNA microarray analysis and quantitative real-time PCR showed that expression of developmentally regulated genes, including myosin heavy chain (MYH) and myogenic transcription factors (MRF4, myogenin and MyoD), in FCMD muscle fibers is inconsistent with dystrophy and active muscle regeneration, instead more of implicating maturational arrest. FCMD skeletal muscle contained mainly immature type 2C fibers positive for immature-type MYH. These characteristics are distinct from Duchenne muscular dystrophy, suggesting that another mechanism in addition to dystrophy accounts for the FCMD skeletal muscle lesion. Immunohistochemical analysis revealed morphologically aberrant neuromuscular junctions (NMJs) lacking MRF4 co-localization. Hypoglycosylated {alpha}-DG indicated a lack of aggregation, and acetylcholine receptor (AChR) clustering was compromised in FCMD and the myodystrophy mouse, another model of secondary {alpha}-DGpathy. Electron microscopy showed aberrant NMJs and neural terminals, as well as myotubes with maturational defects. Functional analysis of NMJs of {alpha}-DGpathy showed decreased miniature endplate potential (MEPP) and higher sensitivities to d-tubocuraline, suggesting abberant or collapsed formation of NMJs. Because {alpha}-DG aggregation and subsequent clustering of AChR are crucial for NMJ formation, hypoglycosylation of {alpha}-DG results in aberrant NMJ formation and delayed muscle terminal maturation in secondary {alpha}-DGpathies. Although severe necrotic degeneration or wasting of skeletal muscle fibers is the main cause of congenital muscular dystrophies, maturational delay of muscle fibers also underlies the etiology of secondary {alpha}-DGpathies.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
M. Kanagawa, A. Nishimoto, T. Chiyonobu, S. Takeda, Y. Miyagoe-Suzuki, F. Wang, N. Fujikake, M. Taniguchi, Z. Lu, M. Tachikawa, et al.
Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy
Hum. Mol. Genet., February 15, 2009; 18(4): 621 - 631.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.